Patents by Inventor Shahram Shawn GHOLAMI

Shahram Shawn GHOLAMI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatments for benign prostatic hyperplasia
    Patent number: 11974979
    Abstract: Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 40 and 400 Centipoise per unit area.
    Type: Grant
    Filed: April 22, 2022
    Date of Patent: May 7, 2024
    Assignee: RESURGE THERAPEUTICS, INC.
    Inventors: Olof Mikael Trollsas, John J. Stankus, Shahram Shawn Gholami
  • Treating benign prostatic hyperplasia
    Patent number: 11957654
    Abstract: Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 40 and 400 Centipoise per unit area.
    Type: Grant
    Filed: December 6, 2022
    Date of Patent: April 16, 2024
    Inventors: Olof Mikael Trollsas, John J. Stankus, Shahram Shawn Gholami
  • APPARATUS FOR TREATING BENIGN PROSTATIC HYPERPLASIA
    Publication number: 20240115544
    Abstract: Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 40 and 400 Centipoise per unit area.
    Type: Application
    Filed: December 4, 2023
    Publication date: April 11, 2024
    Inventors: Olof Mikael TROLLSAS, John J. STANKUS, Shahram Shawn GHOLAMI
  • System and method for prostate treatment
    Patent number: 11911499
    Abstract: A minimally invasive treatment of benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. A method includes introducing a composition into the prostate to achieve a sustained release of the cytostatic or cytotoxic drug over a period of between about 14 days and 12 months.
    Type: Grant
    Filed: November 6, 2020
    Date of Patent: February 27, 2024
    Assignee: Resurge Therapeutics, Inc.
    Inventors: Olof Mikael Trollsas, John J. Stankus, Shahram Shawn Gholami
  • TREATING BENIGN PROSTATIC HYPERPLASIA
    Publication number: 20230248688
    Abstract: Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 40 and 400 Centipoise per unit area.
    Type: Application
    Filed: December 6, 2022
    Publication date: August 10, 2023
    Inventors: Olof Mikael TROLLSAS, John J. STANKUS, Shahram Shawn GHOLAMI
  • TREATMENTS FOR BENIGN PROSTATIC HYPERPLASIA
    Publication number: 20230240979
    Abstract: Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 40 and 400 Centipoise per unit area.
    Type: Application
    Filed: April 22, 2022
    Publication date: August 3, 2023
    Inventors: OLOF MIKAEL TROLLSAS, JOHN J STANKUS, SHAHRAM SHAWN GHOLAMI
  • Treating benign prostatic hyperplasia
    Patent number: 11602516
    Abstract: Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 40 and 400 Centipoise per unit area.
    Type: Grant
    Filed: April 22, 2022
    Date of Patent: March 14, 2023
    Assignee: RESURGE THERAPEUTICS INC.
    Inventors: Olof Mikael Trollsas, John J. Stankus, Shahram Shawn Gholami
  • SYSTEM AND METHOD FOR PROSTRATE TREATMENT
    Publication number: 20220031606
    Abstract: A minimally invasive treatment of benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. A method includes introducing a composition into the prostate to achieve a sustained release of the cytostatic or cytotoxic drug over a period of between about 14 days and 12 months.
    Type: Application
    Filed: November 6, 2020
    Publication date: February 3, 2022
    Inventors: Olof Mikael TROLLSAS, John J. STANKUS, Shahram Shawn GHOLAMI